Intercept Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.10.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT (PR Newswire)
13.10.17	Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH (PR Newswire)
09.10.17	EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm (PR Newswire)
04.10.17	IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm (PR Newswire)
27.09.17	DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intercept Pharmaceuticals, Inc. & Lead Plaintiff Deadline: November 27, 2017 (PR Newswire)
22.09.17	IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns (RTTNews)
14.09.17	Blockchain Foundry Launches Revolutionary Platform for Business Services, Built Entirely on the Syscoin Blockchain (PR Newswire)
13.09.17	TTOO Rallies For 2nd Day, SAGE's STATUS Flops, ICPT Warns Of Ocaliva Overdosing (RTTNews)
12.09.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT (PR Newswire)
01.08.17	Investors: covered-call reports for Advanced Micro Devices, Darden Restaurants, Intercept Pharmaceuticals, Micron and Zillow (PR Newswire)
01.08.17	Gainers & Losers Of July 31: SBBP, AKCA, ACRX, ICPT, ZYNE... (RTTNews)
16.06.17	Daily Technical Summary Reports on Biotech Stocks -- Illumina, Navidea Biopharma, Grifols, and Intercept Pharma (PR Newswire)
18.05.17	Reuters launches Reuters Connect, a content marketplace driven by the needs of modern day publishing (PR Newswire)
17.04.17	How These Biotech Stocks are Faring? -- FibroGen, Bellicum Pharma, Intercept Pharma, and Cellect Biotechnology (PR Newswire)
13.02.17	ICPT Catches Investors' Eyes, TCON Abuzz, IMMU Inks $2Bln Deal With SGEN (RTTNews)
01.02.17	Research Reports Coverage on Biotech Stocks -- Intercept Pharma, Aeterna Zentaris, Spark Therapeutics, and Aratana Therapeutics (PR Newswire)
14.12.16	European Commission Grants Intercept's Ocaliva® (obeticholic acid) Marketing Authorization for the Treatment of Primary Biliary Cholangitis (GlobeNewswire)
06.12.16	Amazon.com trade offers a 6.05% return in 74 days, or find similar option trades on Intercept Pharmaceuticals, Energous Corporation, Opko Health, and 3D Systems (PR Newswire)
14.10.16	Intercept Pharmaceuticals Receives Positive CHMP Opinion for Ocaliva® (Obeticholic Acid) for the... (GlobeNewswire)
17.08.16	New England Journal of Medicine Publishes Results of Phase 3 POISE Trial of Ocaliva® (Obeticholic Acid) for the Treatment of PBC (GlobeNewswire)
28.09.15	Intercept Initiates REGENERATE Trial For Obeticholic Acid In NASH With ALF (RTTNews)
01.09.15	AIMT Is Nothing To Sneeze At, AGRX Secured, TiGenix Admired, ICPT Gets FDA Date (RTTNews)
20.05.15	ACHN Cuts A Deal For HCV Assets, LuViva Snubbed Again, Medidur Proves Safe (RTTNews)
02.03.15	Intercept Pharma Q4 Loss Widens, But Revenues Beat View - Quick Facts (RTTNews)
12.08.14	Intercept Pharma Soars 58% On Positive OCA FLINT Trial Data; Q2 Loss Widens (RTTNews)
08.05.14	Intercept Pharma Posts Wider Q1 Loss On Non-cash Expenses - Quick Facts (RTTNews)
12.04.14	Intercept Pharma Announces Additional Positive Data From POISE Trial (RTTNews)
13.01.14	Intercept Provides Additional Information Regarding FLINT Trial (RTTNews)
09.01.14	Intercept Pharma: NASH Primary Endpoint Met - Quick Facts (RTTNews)
04.10.13	Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA (PR Newswire)
13.08.13	Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results (PR Newswire)
05.08.13	Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Intercept Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten